← Back to Search

Device

MKTP with Surgical Blade for Vitiligo

N/A
Waitlist Available
Led By Anand K Ganesan, MD, PhD
Research Sponsored by University of California, Irvine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Verified diagnosis of vitiligo by a board-certified dermatologist
Candidate for vitiligo treatment as determined by lead researcher
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This trial will compare the efficacy of three different methods for harvesting skin cells for transplantation in the treatment of vitiligo.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percentage of change in the transplanted areas
Percentage of change in the transplanted areas in the transplanted areas
Secondary outcome measures
Rate of Complication
Time of healing

Trial Design

3Treatment groups
Experimental Treatment
Group I: Suction blister grafting without cell dissociationExperimental Treatment1 Intervention
In this arm, transplanting the blisters without dissociation of the cells will be conducted.
Group II: MKTP with Surgical BladeExperimental Treatment1 Intervention
The investigator harvested skin from the donor site and skin from the recipient site using a surgical blade in the first arm of the study.
Group III: MKTP with Negative Pressure InstrumentExperimental Treatment1 Intervention
Blister grafting technique with dissociation of the cells was performed in the second arm of the study.

Find a Location

Who is running the clinical trial?

University of California, IrvineLead Sponsor
536 Previous Clinical Trials
1,921,583 Total Patients Enrolled
Anand K Ganesan, MD, PhDPrincipal InvestigatorUniversity of California, Irvine

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~2 spots leftby Mar 2025